NCT00006903
Fulvestrant in Treating Patients With Recurrent, Persistent, or Metastatic Endometrial Cancer No drug interventions treatment 2 unknown_status NCT00027690
Gefitinib in Treating Patients With Persistent or Recurrent Endometrial Cancer No drug interventions treatment 2 completed NCT02065687
Paclitaxel and Carboplatin With or Without Metformin Hydrochloride in Treating Patients With Stage III, IV, or Recurrent Endometrial Cancer treatment 2 / 3 unknown_status NCT01225887
Nintedanib in Treating Patients With Recurrent or Persistent Endometrial Cancer treatment 2 completed NCT00410553
Eribulin Mesylate and Gemcitabine Hydrochloride in Treating Patients With Metastatic Solid Tumors or Solid Tumors That Cannot be Removed by Surgery treatment 1 completed NCT01440998
Dasatinib, Paclitaxel, and Carboplatin in Treating Patients With Stage III-IV or Recurrent Endometrial Cancer treatment 1 completed NCT02657928
Ribociclib and Letrozole in Treating Patients With Relapsed ER Positive Ovarian, Fallopian Tube, Primary Peritoneal, or Endometrial Cancer treatment 2 completed NCT03552471
Mirvetuximab Soravtansine and Rucaparib Camsylate in Treating Participants With Recurrent Endometrial, Ovarian, Fallopian Tube or Primary Peritoneal Cancer treatment 1 active_not_recruiting NCT00575952
Intraperitoneal Paclitaxel, Doxorubicin Hydrochloride, and Cisplatin in Treating Patients With Stage III-IV Endometrial Cancer treatment 1 completed NCT02208375
mTORC1/2 Inhibitor AZD2014 or the Oral AKT Inhibitor AZD5363 for Recurrent Endometrial and Ovarian treatment 1 / 2 active_not_recruiting NCT00063999
Doxorubicin Hydrochloride, Cisplatin, and Paclitaxel or Carboplatin and Paclitaxel in Treating Patients With Stage III-IV or Recurrent Endometrial Cancer treatment 3 completed NCT00729586
Temsirolimus With or Without Megestrol Acetate and Tamoxifen Citrate in Treating Patients With Advanced, Persistent, or Recurrent Endometrial Cancer treatment 2 completed NCT01210222
Trebananib in Treating Patients With Persistent or Recurrent Endometrial Cancer treatment 2 completed NCT00064025
Medroxyprogesterone in Treating Patients With Endometrioid Adenocarcinoma of the Uterine Corpus treatment 2 completed NCT02996825
Mirvetuximab Soravtansine and Gemcitabine Hydrochloride in Treating Patients With FRalpha-Positive Recurrent Ovarian, Primary Peritoneal, Fallopian Tube, Endometrial, or Triple Negative Breast Cancer treatment 1 completed NCT01098630
Patient, Physician, and Nurse Factors Associated With Entry Onto Clinical Trials and Finishing Treatment in Patients With Primary or Recurrent Uterine, Endometrial, or Cervical Cancer No drug interventions Not Available Not Available completed NCT01010126
Temsirolimus and Bevacizumab in Treating Patients With Advanced Endometrial, Ovarian, Liver, Carcinoid, or Islet Cell Cancer treatment 2 completed NCT00478426
Sunitinib Malate in Treating Patients With Recurrent or Metastatic Endometrial Cancer treatment 2 completed NCT01522820
Vaccine Therapy With or Without Sirolimus in Treating Patients With NY-ESO-1 Expressing Solid Tumors treatment 1 completed NCT02684227
Enzalutamide, Carboplatin, and Paclitaxel in Treating Patients With Stage III-IV or Recurrent Endometrioid Endometrial Cancer treatment 2 completed NCT00006089
Trastuzumab in Treating Patients With Stage III, Stage IV, or Recurrent Endometrial Cancer treatment 2 completed NCT01011933
Selumetinib in Treating Patients With Recurrent or Persistent Endometrial Cancer No drug interventions treatment 2 completed NCT00820898
Gemcitabine in Treating Patients With Recurrent or Persistent Endometrial Cancer No drug interventions treatment 2 completed NCT02578888
Palliative Care in Improving Quality of Life in Patients With High Risk Primary or Recurrent Gynecologic Malignancies No drug interventions supportive_care Not Available completed NCT00897442
Collecting Tumor Samples From Patients With Gynecological Tumors No drug interventions Not Available Not Available completed NCT01164735
Biomarkers in Tumor Tissue Samples From Patients With Stage III, Stage IV, or Recurrent Endometrial Cancer No drug interventions Not Available Not Available completed NCT01970722
Surgery and Chemotherapy With or Without Chemotherapy After Surgery in Treating Patients With Ovarian, Fallopian Tube, Uterine, or Peritoneal Cancer No drug interventions treatment 1 active_not_recruiting NCT01132820
Cediranib Maleate in Treating Patients With Recurrent or Persistent Endometrial Cancer No drug interventions treatment 2 completed NCT01642082
Dalantercept in Treating Patients With Recurrent or Persistent Endometrial Cancer No drug interventions treatment 2 completed NCT01307631
Akt Inhibitor MK2206 in Treating Patients With Recurrent or Advanced Endometrial Cancer No drug interventions treatment 2 completed NCT00888173
Brivanib Alaninate in Treating Patients With Recurrent or Persistent Endometrial Cancer No drug interventions treatment 2 completed NCT01208467
Prognostic Biomarkers in Patients With Endometrial Cancer No drug interventions Not Available Not Available completed NCT01199250
Biomarkers in Samples From Patients With Endometrial Cancer No drug interventions Not Available Not Available withdrawn